IDO1 and melanoma: In this study, we characterized a myeloid activation (MA) signature comprising the three genes Cxcl11, Gbp1, and Ido1. The MA signature indicates the activation state of myeloid cells and represents a prognostic biomarker for the overall survival in melanoma patients.